Accepted Articles > Browse Articles > Accepted Articles



Authors who publish in CMH have an option to make their manuscripts available immediately after acceptance. These “Just Accepted” manuscripts have already been peer-reviewed and approved for publication, but have not yet been proofread or formatted for publication.

When authors choose to take advantage of this CMH service, their papers are uploaded as PDF files with an abstract to the CMHwebsite and available right away to contribute to the research community. When the “Just Accepted” paper is uploaded, this is considered the official publication date, but the “Just Accepted” paper is not considered the final paper of record because the editing process may identify errors to be corrected.

Authors should indicate whether they would like their manuscript uploaded as a “Just Accepted” file when they first submit their paper. It is not possible to change this decision in the middle of the technical editing and formatting process.
A “Just Accepted” manuscript should be cited as an online journal article. To cite a “Just Accepted” manuscript when writing for CMH, follow the guidelines in How to Format the References in the Instructions for Authors section.
Correspondence
Advancing Policy and Practice in Alcohol-Associated Liver Disease and Alcohol-Attributable Cancer: Correspondence to the editorial on “Rising Burden of Alcohol-Associated Liver Disease and Cancers: Insights into Sex Disparities and Policy Implications”
Pojsakorn Danpanichkul, Donghee Kim, Karn Wijarnpreecha, Amit G. Singal, Ju Dong Yang
Received May 13, 2025  Accepted May 14, 2025  
View: 131   Download: 5
Correspondence: Response to Editorial on “Uncovering the MET-TRIB3-FOXO1 axis: A Novel Target in MET-driven Hepatocellular Carcinoma”
Tiantian Wang, Wenjie Huang, Limin Xia
Received May 11, 2025  Accepted May 14, 2025  
View: 128   Download: 6
Editorial
Rising Burden of Alcohol-Associated Liver Disease and Cancers: Insights into Sex Disparities and Policy Implications
Sung-Eun Kim
Received May 9, 2025  Accepted May 13, 2025  
View: 91   Download: 5
Uncovering the MET-TRIB3-FOXO1 axis: A Novel Target in MET-driven Hepatocellular Carcinoma
Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun
Received May 9, 2025  Accepted May 13, 2025  
View: 198   Download: 22
Correspondence
Correspondence: Response to Editorial on “Unveiling TRIB3: A New Mediator in MET-Driven Hepatocellular Carcinoma Progression”
Tiantian Wang, Wenjie Huang, Limin Xia
Received May 6, 2025  Accepted May 8, 2025  
View: 124   Download: 9
Reply to Correspondence
Advancing Metabolic Risk Profiling in Chronic Hepatitis B
Shang-Chin Huang, Jia-Horng Kao
Received May 4, 2025  Accepted May 8, 2025  
View: 99   Download: 5
Correspondence
Correspondence to editorial “Metabolic health in antiviral era of chronic hepatitis B”
Rui Huang, Mindie H. Nguyen
Received April 29, 2025  Accepted May 4, 2025  
View: 119   Download: 1
Research Letter
Contemporary Burden of Mortality from Chronic Liver Disease by Sex and Race/Ethnicity in the United States
Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed
Received April 10, 2025  Accepted May 3, 2025  
View: 114   Download: 12
Correspondence
Correspondence to editorial “Type 2 diabetes as a key metabolic risk factor for adverse outcomes in nucleos(t)ide analogue-treated chronic hepatitis B”
Rui Huang, Mindie H. Nguyen
Received April 29, 2025  Accepted May 3, 2025  
View: 112   Download: 1
Correspondence to letter to the editor on “Risk Stratification of Metabolic Dysfunction-Associated Steatotic Liver Disease: The KASL Pathway
Hye Won Lee, Seung Up Kim
Received April 29, 2025  Accepted May 3, 2025  
View: 116   Download: 2
Research Letter
Non-infectivity of Hepatitis B Virus Under Nucleoside Analog Therapy Revealed Through Auxiliary Partial Orthotopic Liver Transplantation (APOLT)
Xiaojie Chen, Guiwen Guan, Lin Wei, Jidong Jia, Xiangmei Chen, Fengmin Lu, Zhijun Zhu
Received April 9, 2025  Accepted May 1, 2025  
View: 116   Download: 17
Letter to the Editor
Molecular Stratification of Hepatocellular Carcinoma by Metabolic-Signaling Pathways Guides Precision Immunotherapy and TACE Therapy
Binghua Li, Yanchao Xu, Yican Zhu, Yukun Zhang, Zijie Wu, Tianci Luo, Laizhu Zhang, Weiwei Hu, Decai Yu
Received March 27, 2025  Accepted April 29, 2025  
View: 142   Download: 18
Editorial
Type 2 diabetes as a key metabolic risk factor for adverse outcomes in nucleos(t)ide analogue-treated chronic hepatitis B
Heejoon Jang, Won Kim
Received April 16, 2025  Accepted April 25, 2025  
View: 183   Download: 12
Unveiling TRIB3: A New Mediator in MET-Driven Hepatocellular Carcinoma Progression
Many Sze Man CHAN, Terence Kin Wah LEE
Received April 23, 2025  Accepted April 24, 2025  
View: 199   Download: 21
Correspondence
Correspondence to editorial on “Molecular Classification of Hepatocellular Carcinoma based on Zoned Metabolic Feature and Oncogenic Signaling Pathway.”
Tomoko Aoki, Naoshi Nishida, Masatoshi Kudo
Received April 18, 2025  Accepted April 24, 2025  
View: 146   Download: 11
Editorial
RISK STRATIFICATION OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: THE KASL PATHWAY
May Xuan GOH, Xin En GOH, Jarell Jie-Rae TAN, Vincent L CHEN, Yu Jun WONG
Received April 14, 2025  Accepted April 24, 2025  
View: 152   Download: 9
Reply to Correspondence
GULP1: New Hope for Hepatocellular Carcinoma: Reply to Correspondence on “GULP1 as a Novel Biomarker in HCC”
Yuhao Xie, Lu-Qi Cao, John Wurpel, Zhe-Sheng Chen
Received April 14, 2025  Accepted April 24, 2025  
View: 170   Download: 9
Correspondence
Correspondence to editorial “Targeting CD36 to reinvigorate CD8+ T Cells in early-stage hepatocellular carcinoma”
Yifei Qin, Peng Lin, Huijie Bian, Zhi-Nan Chen, Jiao Wu
Received April 11, 2025  Accepted April 24, 2025  
View: 232   Download: 17
Letter to the Editor
Letter “Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target”
Yuqian Liu, Ruiyun Guo, Jun Ma
Received April 6, 2025  Accepted April 21, 2025  
View: 217   Download: 20
Original Article
GLP-1 RA and Reduced Liver and Non-Liver Complications in Adults with T2D and MASLD: A Target Trial Emulation Study
Xianhua Mao, Xinrong Zhang, Rongtao Lai, Ka-Shing Cheung, Man-Fung Yuen, Ramsey Cheung, Wai-Kay Seto, Mindie H Nguyen
Received December 5, 2024  Accepted April 21, 2025  
View: 605   Download: 66
HTD1801 Demonstrates Promising Potential for Histologic Improvements in MASH in Both a Preclinical and Phase 2 Study
Vincent Wai-Sun Wong, Guy W. Neff, Adrian M. Di Bisceglie, Ru Bai, Junwei Cheng, Meng Yu, Alexander Liberman, Liping Liu, Nadege Gunn
Received February 8, 2025  Accepted April 17, 2025  
View: 387   Download: 29
Reply to Correspondence
Reply to authors’ reply: “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
Mathias Jachs, Mattias Mandorfer
Received April 9, 2025  Accepted April 14, 2025  
View: 199   Download: 4
Review
Role of amino acids in the regulation of hepatic gluconeogenesis and lipogenesis in metabolic dysfunction-associated steatotic liver disease
Eiji Kakazu, Masaaki Mino, Tatsuya Kanto
Received January 14, 2025  Accepted April 12, 2025  
View: 688   Download: 99
Correspondence
Correspondence to Editorial on “Switching to Besifovir in Patients with Chronic Hepatitis B Receiving Tenofovir Disoproxil Fumarate: A Randomized Trial”
Hyung Joon Yim, Seong Hee Kang, Young Kul Jung, Jin Mo Yang
Received April 7, 2025  Accepted April 8, 2025  
View: 177   Download: 8
Original Article
Sex Disparities in Alcohol-Associated Liver Disease and Subtype Differences in Alcohol-attributable Cancers in the United States
Pojsakorn Danpanichkul, Yanfang Pang, Tanuj Mahendru, Primrose Tothanarungroj, Luis Antonio Díaz, Juan Pablo Arab, Pimtawan Jatupornpakdee, Mark D. Muthiah, Kwanjit Duangsonk, Won-Mook Choi, Daniel Q. Huang, Donghee Kim, Mazen Noureddin, Karn Wijarnpreecha, Suthat Liangpunsakul, Amit G. Singal, Ju Dong Yang
Received February 12, 2025  Accepted April 8, 2025  
View: 944   Download: 61
MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation
Tiantian Wang, Dean Rao, Chenan Fu, Zhoubin Sun, Yiming Luo, Junli Lu, Jie Jin, Han Li, Feimu Fan, Huifang Liang, Wenjie Huang, Limin Xia
Received December 24, 2024  Accepted April 8, 2025  
View: 838   Download: 114
Editorial
Metabolic Health in Antiviral Era of Chronic Hepatitis B
Shang-Chin Huang, Jia-Horng Kao
Received April 3, 2025  Accepted April 8, 2025  
View: 229   Download: 18
Correspondences
Editorials
Correspondence
Replys to Correspondence
Correspondence
Research Letter
Correspondences
Research Letter
Letter to the Editor
Editorials
Correspondence
Editorial
Reply to Correspondence
Correspondence
Letter to the Editor
Original Articles
Editorial
Reply to Correspondence
Review
Correspondence
Original Articles
Editorials
1 2 3

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1495
TOTAL : 2708460
Close layer